EP 3055286 A1 20160817 - 4-METHYLSULFONYL-2-BUTENENITRILE AND ITS PHARMACEUTICAL USE
Title (en)
4-METHYLSULFONYL-2-BUTENENITRILE AND ITS PHARMACEUTICAL USE
Title (de)
4-METHYLSULFONYL-2-BUTENNITRIL UND DESSEN PHARMAZEUTISCHE VERWENDUNG
Title (fr)
4-MÉTHYLSULFONYL-2-BUTÈNENITRILE ET SON UTILISATION PHARMACEUTIQUE
Publication
Application
Priority
- US 201361887776 P 20131007
- US 2014058685 W 20141001
Abstract (en)
[origin: WO2015054008A1] The present invention is directed to 4-methylsulfonyl-2-butenenitrile, or a pharmaceutically acceptable salt, an isomer, or isomers thereof. The present invention is also directed to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and 4-methylsulfonyl-2-butenenitrile, or a pharmaceutically acceptable salt, an isomer, or isomers thereof. The present invention is directed to a method for treating inflammation, inflammatory-related disorders, or pain, by administering 4-methylsulfonyl-2-butenenitrile, or a pharmaceutically acceptable salt or solvate thereof to a subject in need thereof.
IPC 8 full level
C07C 317/26 (2006.01)
CPC (source: EP)
A61P 17/00 (2017.12); A61P 17/06 (2017.12); A61P 19/00 (2017.12); A61P 19/02 (2017.12); A61P 19/06 (2017.12); A61P 21/00 (2017.12); A61P 29/00 (2017.12); A61P 37/02 (2017.12); C07C 317/44 (2013.01)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2015054008 A1 20150416; CN 105683158 A 20160615; EP 3055286 A1 20160817; EP 3055286 A4 20170524; JP 2016539179 A 20161215; JP 6426746 B2 20181121
DOCDB simple family (application)
US 2014058685 W 20141001; CN 201480055104 A 20141001; EP 14852179 A 20141001; JP 2016546873 A 20141001